(5) regulation
TRANSCRIPT
-
8/10/2019 (5) Regulation
1/66
Regulation of Metabolism
-
8/10/2019 (5) Regulation
2/66
-
8/10/2019 (5) Regulation
3/66
Biological Efficiency
Flexibility: adaptaton to dietarychanges
Need for biosynthetic products Control of pre-existing enzymes
Modulation: biosynthesis only as fast
as needs for macromolecular syntesis
-
8/10/2019 (5) Regulation
4/66
Competing Reactions: Regulation
A
B C
Enzyme 1 Enzyme 2
-
8/10/2019 (5) Regulation
5/66
Kinetic Controls
V1
V2
k1
k2
E1
E2
S1
S2
Km2+ [S2]
Km1+ [S1]
V1=k1[E1][S1]
Km1+ [S1]V2=
k2[E2][S2]
Km2+ [S2]
=
-
8/10/2019 (5) Regulation
6/66
Control Mechanisms
Control of Enzyme Amount Induction and Repression
Catabolite Repression Attenuaton
Control of Enzyme Activity Modulation of k or Vmax(rare)
Control of Kms Control of Substrate Availability
-
8/10/2019 (5) Regulation
7/66
-
8/10/2019 (5) Regulation
8/66
-
8/10/2019 (5) Regulation
9/66
Sites of Regulation
Transcription
initiation
polymerization
termination
Translation
initiation
polymerization
termination
DNA RNAProcessing
splicing
cappingtailing
Translocation
cRNA Proteins
Also
Turnover of RNAs and Proteins
Processing of precursor proteins
Prokaryotes: usually at transcription initiation.
Eukaryotes: can be anywhere!
-
8/10/2019 (5) Regulation
10/66
Types of Regulation
Specific: one pathways substrate orproduct
General: needs for C or N sources orgrowth rates (e.g. energy charge)
-
8/10/2019 (5) Regulation
11/66
Signals Mediating Regulation
Availability of
Substratesor Products(Ligands)
Regulatory Proteins
-
8/10/2019 (5) Regulation
12/66
Gene Organization and Control
Property Prokaryotes Eukaryotes
Regulation Coordinate Coordinate
Organization Operons Dispersed
Magnitude Large Small
Complexity Simple??? ComplexTranscription& Translation
Coupled Uncoupled
-
8/10/2019 (5) Regulation
13/66
Gene Expression in Bacteria
(Operon Model)RNAP
R2
A B C D
R1
P,O L
Transcription
Translation
Attenuation SignalStop Codon(Nonsense)
-
8/10/2019 (5) Regulation
14/66
Upstream Regulatory Sequences
Promoter (general term)
UAS(Upstream Activation Sequence) Enhancers
URS(Upstream Repression Sequence) Operator
-
8/10/2019 (5) Regulation
15/66
Binding of RNA Polymerase to
Promoter
Affected by regulators Affected by strength of promoter:
provides appropriate variation in enzymelevels
-
8/10/2019 (5) Regulation
16/66
Gene Expression in Eukaryotes
Dispersed Genes
-
8/10/2019 (5) Regulation
17/66
Mechanisms of Gene Regulation
Pathway Terminology Ligand RegulatorCatabolic Induction Substrate Negative (lacoperon)
Positive (araoperon)
Anabolic Repression Product Negative (trp operon)
Positive (amino acids in yeast)
-
8/10/2019 (5) Regulation
18/66
Negative Regulators[Bind to operatorsor upstream repression sequences (URS)]
O
O
Inducer
Inducible
e.g. lactose operon
Regulator(Repressor)
Complex
Corepressor
Regulator(Aporepressor)
Complex(Repressor)
Repressible
e.g. trp operon
-
8/10/2019 (5) Regulation
19/66
Positive Regulators[Bind to promoters, enhancersor upstream
activation sequences (UAS)]
O
O +
Inducer
Inducible
e.g. cAMP
Regulator Complex"Activator"
+
Corepressor
Regulator"Activator"
Complex
Repressible
e.g. nit-2
-
8/10/2019 (5) Regulation
20/66
Attenuation in Bacteria(Coupled Transcription and Translation)
DNA
mRNA
Protein
RNA polymerase
Ribosome+
H3N
-
8/10/2019 (5) Regulation
21/66
Mechanism of Attenuation
A B C
5'
"mRNA Leader"
AUG AUGStop Gene(s)
trp codons
Upstream Open Reading Frame (uORF)
NOTE: Negative Regulatory System
-
8/10/2019 (5) Regulation
22/66
Discovery of Attenuation
Charles Yanofsky
-
8/10/2019 (5) Regulation
23/66
Control of Enzyme Activity
-
8/10/2019 (5) Regulation
24/66
Irreversible Covalent Modification
Zymogen Activation
Proteolysis Lysosomes
Proteosomes (ubiquitin)
-
8/10/2019 (5) Regulation
25/66
Reversible Covalent Modification
PP
PP
4 ATP
4 ADP4 H2O
Phosphorylase a "active"
Phosphorylase b "inactive"
+
Phosphorylase
Phosphatase
Phosphorylase
Kinase4 Pi
(glucose)n-1 + glucose-1-PPhosphorylase
(glucose)n + Pi
-
8/10/2019 (5) Regulation
26/66
Non-covalent Modification
Effectors or Ligands
-
8/10/2019 (5) Regulation
27/66
Negative Effectors
"active"
Regulatory Site
Active Site
"inactive" orless active
I
I
+
-
8/10/2019 (5) Regulation
28/66
Positive Effectors
+
"active" ormore active
"inactive" or
poorly active
++
-
8/10/2019 (5) Regulation
29/66
Allosteric Proteins
positive effector
negative effector
no effecto
[S]
Vo
-
8/10/2019 (5) Regulation
30/66
Energy Charge
(Daniel Atkinson)
Steady-State E.C. = 0.93
ATP, ADP and AMP = Regulatory Ligands
Energy Charge 12
2ATP + ADPATP + ADP + AMP
=
-
8/10/2019 (5) Regulation
31/66
Regulation of DegradativePathways
-
8/10/2019 (5) Regulation
32/66
Degradative Pathways
Central Metabolite("Catabolite")
Substrate
-
8/10/2019 (5) Regulation
33/66
Enzyme Amount
Induction(Inducer = Substrate)
Catabolite Repression
b-GalactosidaseLactose Galactose + Glucose
-
8/10/2019 (5) Regulation
34/66
Negative Regulators
O
Inducer
Regulator
(Repressor)
Complex
-
8/10/2019 (5) Regulation
35/66
Positive Regulators
O +
Inducer
Regulator Complex"Activator"
-
8/10/2019 (5) Regulation
36/66
Enzyme Activity
Regulation Unnecessary
No Substrate = No Flux
-
8/10/2019 (5) Regulation
37/66
Lactose Utilization
Lactose Glucose + Galactoseb-galactosidase
E. coli
GlycolysisTCA Cycle
C Source
NOTE: function is to provide carbon andenergy when substrate is available andwhen products are needed.
-
8/10/2019 (5) Regulation
38/66
Regulation of Enzyme Amount
Conditions(C Source)
Enzyme Levels(b-galactosidase)
Terminology
Glucose ~0.0 Uninduced(Basal)
Lactose 1,000 Induction
Lactose +
Glucose
~0.0 Catabolite
Repression
-
8/10/2019 (5) Regulation
39/66
Regulation
Specific Regulation: mediated by availability ofsubstrate called effector (or inducer) e.g.lactose (allolactose) through its interaction with a
regulatory protein. General Regulation: e.g. catabolite repressionanalogous to repression in that endproducteffector (catabolite co-repressor) prevents geneexpression, often by interacting with a regulatory
protein, but may use second messenger system e.g. cAMP.
-
8/10/2019 (5) Regulation
40/66
Physiological Manifestations ofCatabolite Repression
log[cells]
b-galactosidase
cells
b-galactosidase
DiauxicLag
Induction
Use glucoseexclusively
Use lactose
Time
-
8/10/2019 (5) Regulation
41/66
Structure of LacOperon
Z
Structural Genes
Y AOP
-
8/10/2019 (5) Regulation
42/66
RNAP CAP R P O Y A
Stru ctur al Genes
CAPSITE
Z
RNA Polymerase
Structu ral Gen es
cAMP lactose
CAP = catab oliteactivator
p rotein
Regulation of the LacOperon
-
8/10/2019 (5) Regulation
43/66
Requirements for Gene Expression
Availability of Substrate: Lactose (or
allolactose)
and Need for Product: low [glucose) > cAMP
-
8/10/2019 (5) Regulation
44/66
Mechanism of Catabolite Repression
ATP
HPr
COOH
C
CH2
OP
PEP
Pyruvate
EI
EI~P
HPr~P EIIIg
EIIIg~P
Glucose
Glucose-6-P
PPi+ cAMP
AdenylateCyclase
Activation
EIIg
SolubleCytoplasmic
Proteins(Common)
-
8/10/2019 (5) Regulation
45/66
Inducible Operon(Positive Regulator)
+
o
A B C DRNAPR
UAS L
Amino Acid
P
Binding of amino acid is required
to activate positive transcripiton
factor (regulator)
-
8/10/2019 (5) Regulation
46/66
HutOperon of Klebsiella aerogenes
-
8/10/2019 (5) Regulation
47/66
Pathway
-
8/10/2019 (5) Regulation
48/66
Regulation
C Source N Source His +His His +His
Glucose NH3 0 0 0 0
Glucose Limit NH3 0 105 100 100
Limit Glc NH3 0 120 100 100
Limit Glc Limit NH3 0 120 100 100
hisR+Enzyme Levels hisRCEnzyme Levels
-
8/10/2019 (5) Regulation
49/66
Mechanism of Regulation
RN AP R 2CAP R 1 A B C D
Structural Genes
cAMP low gln
P,O
his
either one
Carbon Catabolite Repression
Nitrogen Metabolite Repression
-
8/10/2019 (5) Regulation
50/66
Regulation of BiosyntheticPathways
-
8/10/2019 (5) Regulation
51/66
Biosynthetic Pathways
ATP
CentralMetabolite
Product(Amino Acid)
ADP + Pi
-
8/10/2019 (5) Regulation
52/66
Enzyme Amount
Repression
Endproduct = Corepressor
-
8/10/2019 (5) Regulation
53/66
Negative Regulator
O
Corepressor
Regulator(Aporepressor)
Complex(Repressor)
-
8/10/2019 (5) Regulation
54/66
Positive Regulators
O+
Corepressor
Regulator"Activator"
Complex
-
8/10/2019 (5) Regulation
55/66
Enzyme Activity
Feedback Inhibition
Endproduct = Ligand or Effector
-
8/10/2019 (5) Regulation
56/66
Simple Feedback Inhibition
X
ATP
CentralMetabolite
Product(Amino Acid)
ADP + Pi
-
8/10/2019 (5) Regulation
57/66
Complex Feedback Inhibition
CentralMetabolite
Product 1
Product 2
XX
X
-
8/10/2019 (5) Regulation
58/66
Mechanisms of Complex FeedbackInhibition
Cumulative: sum of individual inhibitions
Concerted: both end products required forinhibition
Isoenzyme: two enzymes, each inhibitableby different end product
Sequential: inhibition by accumulatingintermediate
-
8/10/2019 (5) Regulation
59/66
Amino Acid Biosynthetic Operon
Positive Regulator
-
8/10/2019 (5) Regulation
60/66
Pathway
CentralMetabolite
Amino
Acid
-
8/10/2019 (5) Regulation
61/66
Regulation
+
o
A B C DRNAPR
UAS L
Transcription
Translation
Stop Codon(Nonsense)
Amino Acid
Start Codon
P
-
8/10/2019 (5) Regulation
62/66
Eukaryotes versusProkaryotes
-
8/10/2019 (5) Regulation
63/66
Properties
Increased Size: reduced membranesurface to volume ratio
Increased Complexity: limitedsolvent capacity
Uncoupled Transcription and
Translation: slower gene expression
-
8/10/2019 (5) Regulation
64/66
Evolutionary Response
Organelles
Constitutive Enzymes
-
8/10/2019 (5) Regulation
65/66
Problems
Intracellular Metabolite Transport
Competing Pathways
-
8/10/2019 (5) Regulation
66/66
Regulatory Solutions
Separate Metabolic Pathways Different intermediates Different enzymes (control of enzyme
activities) Physical Separation of Metabolic Pathways
Location Multienzyme Complexes
(Control of Substrate Availability)